 | Up a level |
Hagel, Stefan 
ORCID: 0000-0003-2999-6131, Fiedler, Sandra, Hohn, Andreas, Brinkmann, Alexander, Frey, Otto R., Hoyer, Heike, Schlattmann, Peter, Kiehntopf, Michael, Roberts, Jason A., Pletz, Mathias W., Bloos, Frank, Angermair, Stefan, Bracht, Hendrik, Barth, Eberhard, Kluge, Stefan, Nierhaus, Axel, Motsch, Johann, Brenner, Thorsten, Annecke, Thorsten ORCID: 0000-0002-2496-4432, Bach, Friedhelm, Weigand, Markus, Schappacher, Markus, von Ameln-Mayerhofer, Andreas, Michels, Guido, Roehr, Anka, Fuchs, Thomas, Eichner, Sarah, Barth, Eberhard, Kong, Christina, Pinder, Nadine, Mueller, Carsten, Petersen, Miriam, Schlattmann, Peter, Steinbach, Gerald, Jarczak, Dominik, Weisman, Dirk, Kurlbaum, Max and Braune, Anke
(2019).
Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Trials, 20.
LONDON:
BMC.
ISSN 1745-6215